Elizabeth F. Chen

Born and raised in China and bilingual in Mandarin and English, Elizabeth brings to her counsel a natural advantage when representing China-based companies doing business in the United States. She combines her skill in bridging cultural gaps with practical, business-oriented advice to help clients reach their corporate objectives.

Elizabeth’s general corporate and securities law practice focuses on representing corporations in the pharmaceutical, life sciences, manufacturing, software, and technology industries listed on U.S. major stock exchanges including NYSE, NASDAQ, and NYSE MKT. She also works with private businesses in China seeking to go public in the U.S. and advises public companies going private. Elizabeth brings deep experience in:

• Initial public offerings (IPOs)
• Reverse mergers
• Cross-border transactions involving public and private mergers, stock and asset acquisitions, and private placements SEC registration statement filings under the Securities Act of 1933 and reports under the Securities Exchange Act of 1934
• SEC, FINRA, and internal investigations
• Stock exchange listings and compliance
• Going-private transactions

Always Willing to Go the Extra Mile

Dedicated, responsible, and analytical, Elizabeth is a strong advocate for her clients. Maintaining an open dialogue with SEC staff members, she facilitates the SEC comment process and navigates the complexities associated with listings on the stock exchanges. Elizabeth’s ability to leverage her extensive network of contacts, both in the U.S. and China, also allows her to deliver important benefits to her clients.